FOXO3 and colorectal cancer: Interestingly, FOXO3A inhibits cyclin D1 expression in colorectal cancer as well as breast cancer [43,44] whereas GSK3 phosphorylates cyclin D1 on Thr286, leading to ubiquitination and proteasomal degradation of cyclin D1 [45,46].